Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-06-28
2005-06-28
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S638000, C514S773000, C514S611000, C514S934000, C514S788100, C514S183000
Reexamination Certificate
active
06911478
ABSTRACT:
The present invention relates to nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions comprising such compounds, methods of using such compounds and compositions, and to a method for the preparation of nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates via the direct reaction of nitric oxide with amidines and enamines, and to a method of converting amines into such compounds.
REFERENCES:
patent: 4954526 (1990-09-01), Keefer
patent: 5155137 (1992-10-01), Keefer et al.
patent: 5212204 (1993-05-01), Keefer et al.
patent: 5674894 (1997-10-01), Currie et al.
patent: 5770645 (1998-06-01), Stamler et al.
patent: 6232336 (2001-05-01), Hrabie et al.
patent: 122080 (1976-09-01), None
patent: WO 93/13055 (1993-07-01), None
patent: WO 94/27957 (1994-12-01), None
patent: WO 95/05363 (1995-02-01), None
patent: 9505363 (1995-02-01), None
patent: WO 96/36639 (1996-11-01), None
patent: WO 96/40665 (1996-12-01), None
Bogdan C., PubMed Abstract 11577346, also cited asNat. Immunol., 2(10), 907-916 (2001).
Chabrier et al., PubMed Abstract 10442086, also cited asCell. Mol. Life Sci., 55(8-9), 1029-1035 (1999).
Derwent Abstract AN-85-047728, Derwent Publications Ltd., “New N, N′-dihydroxydiazenium Propanol Derivative for Prevention and Treatment of Apple Canker” (Jan. 14, 1985).
Feldman et al.,C&EN, 26-38 (1993).
Freeman et al., “Alkaline Decomposition of Nitrosohydroxylamine Derivatives,”J. Org. Chem., 35(9), 3107-3110 (1970).
Le Corvoiser et al., PubMed Abstract 11324316, also cited asJ. Soc. Biol., 194(3-4), 143-149 (2000).
Nathan C.,FASEB, 6, 3051-3063 (1993).
Oka et al., PubMed Abstract 12909236, also cited asInt. J. Radiat. Oncol. Biol. Phys., 57(1), 217-221 (2003).
Turunen et al., PubMed Abstract 10817812, also cited asExp. Gerontol., 34(4), 567-574 (1999).
Volodarskii et al., “Preparation and Properties of N-nitroso-alpha-hydroxylamino Oximes,”Chemical Abstracts, 85(21), abstract No. 15959w (1976).
Wang et al., PubMed Abstract 12856639, also cited asUrol. Oncol., 21(2), 117-122 (2003).
Arnold et al.,Tetrahedron Letters, 41, 8421-8424 (2000).
Boschi et al.,Bioorg. Med. Chem., 8, 1727-1732 (2000).
Cantuaria et al.,Cancer, 88(2), (Abstract) 381-388 (2000).
Etchenique et al.,J. Am. Chem. Soc.,122, 3967-3968 (2000).
Hou et al.,Bioorg. Med. Chem. Lett.,9(15) (Abstract) 2255-2258 (1999).
Hrabie et al.,Bioconjugate Chem., 10, 838-842 (1999).
Severnia et al.,Biochem. and Mol. Bio. Int.,36(4), 913-925 (Jul. 1995).
Soulere et al.,Bioorg. Med. Chem. Lett.,10(12), 1347-1350 (2000).
Southan et al.,Nitric Oxide: Bio and Chem.,2(4), 270-286 (1998).
Tsumori et al.,Acta Biochem. Pol., 49(1), (Abstract) 139-144 (2002).
Hrabie Joseph A.
Keefer Larry K.
Patel Sudhaker B.
Raymond Richard L.
The United States of America as represented by the Department of
LandOfFree
Nitric oxide-releasing amidine- and enamine-derived... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide-releasing amidine- and enamine-derived..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide-releasing amidine- and enamine-derived... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3472177